Content about Pharmaceutical sciences

January 9, 2014

Bi-Lo and Winn-Dixie will cover initial prescription costs for customers who have enrolled in the health insurance marketplaces, but don't yet have their identification cards, the chains said.

GREENVILLE, S.C. — Bi-Lo and Winn-Dixie will cover initial prescription costs for customers who have enrolled in the health insurance marketplaces, but who don't yet have their identification cards, the chains said.

The supermarket chains, both banners owned by Bi-Lo Holdings, will offer 30-day supplies of most prescription drugs at no upfront cost to health insurance marketplace enrollees until Jan. 31.

January 9, 2014

The Jean Coutu Group posted a boost in third-quarter net profits as revenues decreased largely because of the growth in generic drug prescriptions.

LONGUEIL, Quebec — The Jean Coutu Group posted a boost in third-quarter net profits as revenues decreased largely because of the growth in generic drug prescriptions.

January 9, 2014

Rather than take vacation for Christmas and New Year’s, the editors of DSN worked to compile a list of the top 10 trends that will shake up the business in 2014.

Rather than take vacation for Christmas and New Year’s, the editors of DSN worked to compile a list of the top 10 trends that will shake up the business in 2014.

Clinics explode onto scene

Keep a close eye on retail-based health clinics come 2014.

The convenient care industry has come far since hitting the scene in 2000 and today — with nearly 1,500 clinics nationwide — they are proving their importance within the changing healthcare landscape.

January 9, 2014

Mylan has launched a generic drug for preventing rejection of transplanted organs, the company said Thursday.

PITTSBURGH — Mylan has launched a generic drug for preventing rejection of transplanted organs, the company said Thursday.

The generic drug maker announced the launch of mycophenolic acid delayed-release tablets in the 180-mg and 360-mg strengths. The drug is a generic version of Novartis' Myfortic. As the first company to file a completed regulatory approval application for the generic, Mylan is entitled to 180 days in which to compete exclusively against Novartis' product before the Food and Drug Administration can approve additional generic versions.

January 9, 2014

Vulnerable patients, including seniors and cancer patients, suffer from lack of access to needed painkillers as efforts to combat diversion and misuse of controlled substances often result in drugs not getting into the hands of those who need them, according to a new pharmacist survey by the National Community Pharmacists Association.

ALEXANDRIA, Va. —Vulnerable patients, including seniors and cancer patients, suffer from lack of access to needed painkillers as efforts to combat diversion and misuse of controlled substances often result in drugs not getting into the hands of those who need them, according to a new pharmacist survey by the National Community Pharmacists Association. 

January 9, 2014

A confluence of healthcare trends has expanded a lucrative, if challenging, opportunity for pharmacies able to invest in its potential.

A confluence of healthcare trends has expanded a lucrative, if challenging, opportunity for pharmacies able to invest in its potential.

January 9, 2014

The head of the country's largest e-prescribing network is stepping down, the company said Thursday.

ARLINGTON, Va. — The head of the country's largest e-prescribing network is stepping down, the company said Thursday.

Surescripts announced that president and CEO Harry Totonis would leave the company in March. Totonis began with the company following its 2008 merger with RxHub.

Surescripts' board of directors is retaining an executive search firm to find a successor, and a spokeswoman for the company told DSN that it was actively looking for a replacement with Totonis' help, and did not have plans to appoint an interim CEO at this time.

January 9, 2014

Teva Pharmaceutical Industries has appointed Erez Vigodman as president and CEO, the Israeli drug maker said Thursday.

JERUSALEM — Teva Pharmaceutical Industries has appointed Erez Vigodman as president and CEO, the Israeli drug maker said Thursday.

Vigodman will replace acting president and CEO Eyal Desheh, who will return to his previous position as group EVP and CFO. Desheh took the interim position after the departure of former president and CEO Jeremy Levin in October 2013.

January 8, 2014

Aetna has announced that Walmart and Sam’s Club pharmacies have been added to the preferred pharmacy network of the Aetna CVS/pharmacy Prescription Drug Plan as of Jan. 1.

HARTFORD, Conn. — Aetna has announced that Walmart and Sam’s Club pharmacies have been added to the preferred pharmacy network of the Aetna CVS/pharmacy Prescription Drug Plan as of Jan. 1.

January 8, 2014

The Food and Drug Administration has approved a new drug made by Bristol-Myers Squibb and AstraZeneca for treating Type 2 diabetes, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Bristol-Myers Squibb and AstraZeneca for treating Type 2 diabetes, the agency said Wednesday.

The FDA announced the approval of Farxiga (dapagliflozin) tablets, designed for use with exercise and dietary adjustments to control blood sugar. Type 2 diabetes affects about 24 million people in the United States, accounting for more than 90% of diabetes cases.

January 8, 2014

Takeda Pharmaceutical has started a late-stage clinical trial program of its experimental drug for inflammatory bowel disease in Japan, the company said Wednesday.

OSAKA, Japan — Takeda Pharmaceutical has started a late-stage clinical trial program of its experimental drug for inflammatory bowel disease in Japan, the company said Wednesday.

Takeda announced the start of two phase-3 trials of MLN0002 (vedolizumab) in patients with severe ulcerative colitis and Crohn's disease. The trials are designed to find out the efficacy, safety and effects on the body of the drug, particularly to see if patients show a response after 10 weeks of treatment and disease remission after 60 weeks.

January 8, 2014

Walgreens is not only completely transforming its drug store business from a prescription medicine dispensary to healthcare provider, they're continuing to deliver shareholder value.

CHICAGO — Walgreens is not only completely transforming its drug store business from a prescription medicine dispensary to healthcare provider, they're continuing to deliver shareholder value. Since the chain implemented its "Plan to Win" strategy five years ago, kicking off Walgreens journey to reinvent and innovate the storied drug store chain for a new era of growth and value creation, Walgreens has delivered 145% in shareholder returns vs. the 118% return realized by the S&P 500 in the same period. 

January 7, 2014

Ani Pharmaceuticals has bought 31 generic drugs from Teva Pharmaceuticals for $12.5 million, the company said.

BAUDETTE, Minn. — Ani Pharmaceuticals has bought 31 generic drugs from Teva Pharmaceuticals for $12.5 million, the company said.

January 7, 2014

Big Y pharmacies and En-Vision America have recently partnered on a pair of novel programs designed to improve compliance among seniors with impaired vision.

SPRINGFIELD, Mass. — Big Y pharmacies and En-Vision America have recently partnered on a pair of novel programs designed to improve compliance among seniors with impaired vision. 

"The pharmacists are engaging with all patients and making them aware of this new service," Jan Winn, Big Y director of pharmacy, HABC and GM, shared with DSN. "The larger print labels are a big hit with the 'babyboom' generation."

January 7, 2014

The Consumer Healthcare Products Association reported the makers of over-the-counter pediatric liquid medications have made significant progress in carrying out voluntary efforts to promote safe use through standardized dosing directions and dosing devices, as underscored by the results of a Centers for Disease Control and Prevention study released Monday in Pediatrics.

WASHINGTON — The Consumer Healthcare Products Association reported the makers of over-the-counter pediatric liquid medications have made significant progress in carrying out voluntary efforts to promote safe use through standardized dosing directions and dosing devices, as underscored by the results of a Centers for Disease Control and Prevention study released Monday in Pediatrics.

January 7, 2014

Navarro Discount Pharmacy has been recognized as a winner of the 2013 UnitedHealthcare Medication Adherence Targeted Intervention Program Challenge benefiting the National Association of Chain Drug Stores Foundation.

MIAMI — Navarro Discount Pharmacy has been recognized as a winner of the 2013 UnitedHealthcare Medication Adherence Targeted Intervention Program Challenge benefiting the National Association of Chain Drug Stores Foundation.

Navarro was recognized in the small retail pharmacy chain and independent community pharmacy category for its ability to address gaps in medication adherence among a subgroup of UnitedHealthcare Medicare Advantage-Part D plan members.

January 7, 2014

The National Community Pharmacists Association on Tuesday expressed support of several policy changes proposed by the Centers for Medicare and Medicaid Services.

ALEXANDRIA, Va. — The National Community Pharmacists Association on Tuesday expressed support of several policy changes proposed by the Centers for Medicare and Medicaid Services, according to a document filed in the Federal Register. 

January 7, 2014

Publix on Tuesday announced plans to expand a new Sync Your Refills program to all pharmacies. After a successful test in the Atlanta Division, the program will expand companywide to the remaining Publix Pharmacies by Friday, Jan. 24.

LAKELAND, Fla. — Publix on Tuesday announced plans to expand a new Sync Your Refills program to all pharmacies. After a successful test in the Atlanta Division, the program will expand companywide to the remaining Publix Pharmacies by Friday, Jan. 24. 

January 7, 2014

Retail pharmacy veteran Dan Haron has been appointed CEO of NuScriptRx, which serves the pharmaceutical needs of long-term care facilities and their residents, according to published reports.

NASHVILLE — Retail pharmacy veteran Dan Haron has been appointed CEO of NuScriptRx, which serves the pharmaceutical needs of long-term care facilities and their residents, according to published reports.

Haron previously served as president of Cigna pharmacy management. He joined Cigna in 2007 as VP operations for Cigna tele-drug home delivery pharmacy.

January 6, 2014

The ability of most accountable care organizations to promote optimal use of medications has not yet been developed, according to a new study.

WASHINGTON — The ability of accountable care organizations to promote optimal use of medications has not yet been fully developed, according to a new study.

January 6, 2014

Amneal Pharmaceuticals has launched an authorized generic version of a recently launched drug for gastroesophageal reflux disease, the company said.

BRIDGEWATER, N.J. — Amneal Pharmaceuticals has launched an authorized generic version of a recently launched drug for gastroesophageal reflux disease, the company said Monday.

January 6, 2014

Diabetic users of an online patient portfolio for medication refills improved their adherence to cholesterol-lowering medications and improved their cholesterol levels, according to a new study.

OAKLAND, Calif. — Diabetic users of an online patient portfolio for medication refills improved their adherence to cholesterol-lowering medications and improved their cholesterol levels, according to a new study.

January 6, 2014

VoicePort announced that they have launched their Medication Synchronization Program, SynchroScript, along with two of their other adherence services with Tops Friendly Markets Pharmacy, of Williamsville, N.Y.

ROCHESTER, N.Y. — VoicePort on Monday announced that they have launched their Medication Synchronization Program, SynchroScript, along with two of their other adherence services with Tops Friendly Markets Pharmacy, of Williamsville, N.Y. 

January 6, 2014

Walgreens reported December sales of $7.2 billion, an increase of 7.2%. Sales in comparable stores increased by 6.1% in December.

DEERFIELD, Ill. — Walgreens on Monday reported December sales of $7.2 billion, an increase of 7.2%. Sales in comparable stores increased by 6.1% in December. Calendar day shifts positively impacted total comparable sales by 170 basis points, while generic drug introductions in the last 12 months negatively impacted total comparable sales by 70 basis points. December 2013 had one additional Tuesday and one fewer Saturday compared with December 2012. 

January 3, 2014

Regional chain Kinney Drugs is the latest to offer prescriptions at no upfront cost to some customers who have enrolled in Obamacare, according to published reports.

NEW YORK — Regional chain Kinney Drugs is the latest to offer prescriptions at no upfront cost to some customers who have enrolled in Obamacare, according to published reports.

The Syracuse, N.Y., Post-Standard reported Friday that the Gouverneur, N.Y.-based chain would offer 30-day prescriptions to customers who have enrolled, but have not received an identification number. The offer is good through the month of January. Kinney operates 99 stores in central and northern New York and adjacent areas of Vermont.